This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Oct 6;173(7):595-596.

doi: 10.7326/L20-1056.

Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes

Emanuele Angelucci¹, Peter Greenberg², Miguel Izquierdo³, Guillermo Garcia-Manero⁴

Affiliations

Affiliations

¹ IRCCS Ospedale Policlinico San Martino, Genova, Italy (E.A.).
² Stanford University Medical Center, Stanford, California (P.G.).
³ Novartis Pharma AG, Basel, Switzerland (M.I.).
⁴ MD Anderson Cancer Center and University of Texas, Houston, Texas (G.G.).

PMID: 33017548
DOI: 10.7326/L20-1056

Comment

Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes

Emanuele Angelucci et al. Ann Intern Med. 2020.

. 2020 Oct 6;173(7):595-596.

doi: 10.7326/L20-1056.

Authors

Emanuele Angelucci¹, Peter Greenberg², Miguel Izquierdo³, Guillermo Garcia-Manero⁴

Affiliations

¹ IRCCS Ospedale Policlinico San Martino, Genova, Italy (E.A.).
² Stanford University Medical Center, Stanford, California (P.G.).
³ Novartis Pharma AG, Basel, Switzerland (M.I.).
⁴ MD Anderson Cancer Center and University of Texas, Houston, Texas (G.G.).

PMID: 33017548
DOI: 10.7326/L20-1056

No abstract available

PubMed Disclaimer

Comment on

Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes: A Randomized Trial.
Angelucci E, Li J, Greenberg P, Wu D, Hou M, Montano Figueroa EH, Rodriguez MG, Dong X, Ghosh J, Izquierdo M, Garcia-Manero G; TELESTO Study Investigators. Angelucci E, et al. Ann Intern Med. 2020 Apr 21;172(8):513-522. doi: 10.7326/M19-0916. Epub 2020 Mar 24. Ann Intern Med. 2020. PMID: 32203980 Clinical Trial.
Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes.
Lucijanic M, Lovrinov M, Skelin M. Lucijanic M, et al. Ann Intern Med. 2020 Oct 6;173(7):595. doi: 10.7326/L20-1055. Ann Intern Med. 2020. PMID: 33017549 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information